About: Pulmocide

An Entity of Type: Privately held company, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Pulmocide is a privately held biopharmaceutical company focusing on the discovery and development of inhaled medicine for the treatment of life-threatening fungal and viral infections of the respiratory tract. The company is based in London and has a laboratory at the Imperial College’s Innovation Hub.

Property	Value
dbo:abstract	Pulmocide is a privately held biopharmaceutical company focusing on the discovery and development of inhaled medicine for the treatment of life-threatening fungal and viral infections of the respiratory tract. The company is based in London and has a laboratory at the Imperial College’s Innovation Hub. (en)
dbo:industry	dbr:Drug_discovery dbr:Biopharmaceutical dbr:Medicine
dbo:keyPerson	dbr:CEO dbr:Chief_scientific_officer
dbo:regionServed	dbr:European_Union
dbo:thumbnail	wiki-commons:Special:FilePath/Pulmocide_Company_Logo.jpg?width=300
dbo:type	dbr:Privately_held_company
dbo:wikiPageID	61029628 (xsd:integer)
dbo:wikiPageLength	5469 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1081892297 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Privately_held_company dbc:Pharmaceutical_companies_established_in_2007 dbr:Antifungal dbr:Human_orthopneumovirus dbr:Johnson_&_Johnson dbr:Peter_J._Barnes_(respiratory_scientist) dbr:Cystic_fibrosis dbr:United_Kingdom dbr:Chief_executive_officer dbr:Mycosis dbr:London dbr:Lung_transplantation dbr:Clinical_trial dbr:CEO dbr:Drug_discovery dbr:European_Union dbr:Severe_acute_respiratory_syndrome_coronavirus_2 dbr:Asthma dbr:Chief_scientific_officer dbr:Biopharmaceutical dbr:Aspergillus dbc:Organisations_associated_with_Imperial_College_London dbr:Imperial_College_London dbr:Medicine dbr:In_silico dbr:Science_Advances dbr:Respiratory_tract dbr:Viral_disease
dbp:areaServed	dbr:European_Union
dbp:industry	dbr:Drug_discovery dbr:Biopharmaceutical dbr:Medicine
dbp:keyPeople	Peter Strong (en) Garth Rapeport, (en)
dbp:location	dbr:Imperial_College_London
dbp:locationCountry	dbr:United_Kingdom
dbp:logo	Pulmocide_Company_Logo.jpg (en)
dbp:name	Pulmocide (en)
dbp:type	dbr:Privately_held_company
dbp:wikiPageUsesTemplate	dbt:Infobox_company dbt:Official_website dbt:Orphan dbt:Reflist dbt:Start_date_and_age dbt:URL dbt:Use_dmy_dates
dcterms:subject	dbc:Pharmaceutical_companies_established_in_2007 dbc:Organisations_associated_with_Imperial_College_London
rdf:type	owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 dbo:Organisation
rdfs:comment	Pulmocide is a privately held biopharmaceutical company focusing on the discovery and development of inhaled medicine for the treatment of life-threatening fungal and viral infections of the respiratory tract. The company is based in London and has a laboratory at the Imperial College’s Innovation Hub. (en)
rdfs:label	Pulmocide (en)
owl:sameAs	wikidata:Pulmocide https://global.dbpedia.org/id/A12jb
prov:wasDerivedFrom	wikipedia-en:Pulmocide?oldid=1081892297&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Pulmocide_Company_Logo.jpg
foaf:homepage	http://pulmocide.com
foaf:isPrimaryTopicOf	wikipedia-en:Pulmocide
foaf:name	Pulmocide (en)
is dbo:wikiPageWikiLink of	dbr:Kate_Bingham
is foaf:primaryTopic of	wikipedia-en:Pulmocide

This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License